Randomised phase II study of docetaxel plus vandetanib versus docetaxel followed by vandetanib in patients with persistent or recurrent epithelial ovarian, fallopian tube or primary peritoneal carcinoma: SWOG S0904

✍ Scribed by Coleman, Robert L.; Moon, James; Sood, Anil K.; Hu, Wei; Delmore, James E.; Bonebrake, Albert J.; Anderson, Garnet L.; Chambers, Setsuko K.; Markman, Maurie

• Book ID: 122303723
• Publisher: Elsevier Science
• Year: 2014
• Tongue: English
• Weight: 887 KB
• Volume: 50
• Category: Article
• ISSN: 0959-8049
• DOI: 10.1016/j.ejca.2014.03.005